276 related articles for article (PubMed ID: 28482407)
21. Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report.
Kaufmann S; Schulze M; Spira D; Horger M
Acta Radiol; 2016 Jan; 57(1):8-12. PubMed ID: 25585848
[TBL] [Abstract][Full Text] [Related]
22. Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
Choi SJ; Kim J; Seo J; Kim HS; Lee JM; Park H
Abdom Imaging; 2014 Jun; 39(3):518-25. PubMed ID: 24519566
[TBL] [Abstract][Full Text] [Related]
23. Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation.
Kwan SW; Fidelman N; Ma E; Kerlan RK; Yao FY
Liver Transpl; 2012 Jun; 18(6):727-36. PubMed ID: 22344899
[TBL] [Abstract][Full Text] [Related]
24. Local recurrence of hepatocellular carcinoma after segmental transarterial chemoembolization: risk estimates based on multiple prognostic factors.
Park SH; Cho YK; Ahn YS; Park YO; Kim JK; Chung JW
Korean J Radiol; 2007; 8(2):111-9. PubMed ID: 17420628
[TBL] [Abstract][Full Text] [Related]
25. Comparison of local control in transcatheter arterial chemoembolization of hepatocellular carcinoma ≤6 cm with or without intraprocedural monitoring of the embolized area using cone-beam computed tomography.
Miyayama S; Yamashiro M; Hashimoto M; Hashimoto N; Ikuno M; Okumura K; Yoshida M; Matsui O
Cardiovasc Intervent Radiol; 2014 Apr; 37(2):388-95. PubMed ID: 23775550
[TBL] [Abstract][Full Text] [Related]
26. Spectral CT in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma: A retrospective study.
Wang J; Shen JL
Medicine (Baltimore); 2017 Dec; 96(52):e9236. PubMed ID: 29384909
[TBL] [Abstract][Full Text] [Related]
27. Quantitative analysis with multiphase contrast-enhanced computed tomography to evaluate residual tumor activity of hepatocellular carcinoma after DEB-TACE.
Hu W; Cao G; Ye S; Xu J; Chen J; Shao G
Medicine (Baltimore); 2023 Jun; 102(24):e34054. PubMed ID: 37327303
[TBL] [Abstract][Full Text] [Related]
28. Dose Optimization of Perfusion-derived Response Assessment in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: Comparison of Volume Perfusion CT and Iodine Concentration.
Thaiss WM; Haberland U; Kaufmann S; Hepp T; Schulze M; Blum AC; Ketelsen D; Nikolaou K; Horger M; Sauter AW
Acad Radiol; 2019 Sep; 26(9):1154-1163. PubMed ID: 30482626
[TBL] [Abstract][Full Text] [Related]
29. Role of diffusion-weighted imaging in evaluating therapeutic efficacy after transcatheter arterial chemoembolization for hepatocellular carcinoma.
Kubota K; Yamanishi T; Itoh S; Murata Y; Miyatake K; Yasunami H; Morio K; Hamada N; Nishioka A; Ogawa Y
Oncol Rep; 2010 Sep; 24(3):727-32. PubMed ID: 20664980
[TBL] [Abstract][Full Text] [Related]
30. Parametric response mapping of dynamic CT for predicting intrahepatic recurrence of hepatocellular carcinoma after conventional transcatheter arterial chemoembolization.
Choi SJ; Kim J; Seo J; Kim HS; Lee JM; Park H
Eur Radiol; 2016 Jan; 26(1):225-34. PubMed ID: 25991485
[TBL] [Abstract][Full Text] [Related]
31. Dense accumulation of lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization: measurement of balloon-occluded arterial stump pressure.
Irie T; Kuramochi M; Takahashi N
Cardiovasc Intervent Radiol; 2013 Jun; 36(3):706-13. PubMed ID: 22996589
[TBL] [Abstract][Full Text] [Related]
32. The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.
Lee JW; Yun M; Cho A; Han KH; Kim DY; Lee SM; Lee JD
Ann Nucl Med; 2015 Jun; 29(5):400-8. PubMed ID: 25652647
[TBL] [Abstract][Full Text] [Related]
33. Preoperative Nomogram Incorporating Clinical Factors, Serological Markers and LI-RADS MRI Features to Predict Early Recurrence of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
Sheng Y; Wang Q; Liu HF; Chen WH; He ZM; Wang Q
Acad Radiol; 2023 Jul; 30(7):1288-1297. PubMed ID: 36424310
[TBL] [Abstract][Full Text] [Related]
34. Quantitative assessment of angiographic perfusion reduction using color-coded digital subtraction angiography during transarterial chemoembolization.
Wang J; Cheng JJ; Huang KY; Zhuang ZG; Zhang XB; Chi JC; Hua XL; Xu JR
Abdom Radiol (NY); 2016 Mar; 41(3):545-52. PubMed ID: 27039326
[TBL] [Abstract][Full Text] [Related]
35. Early response evaluation using CT-perfusion one day after transarterial chemoembolization for HCC predicts treatment response and long-term disease control.
Tamandl D; Waneck F; Sieghart W; Unterhumer S; Kölblinger C; Baltzer P; Ba-Ssalamah A; Loewe C
Eur J Radiol; 2017 May; 90():73-80. PubMed ID: 28583650
[TBL] [Abstract][Full Text] [Related]
36. MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Kloeckner R; Otto G; Biesterfeld S; Oberholzer K; Dueber C; Pitton MB
Cardiovasc Intervent Radiol; 2010 Jun; 33(3):532-40. PubMed ID: 19847482
[TBL] [Abstract][Full Text] [Related]
37. Prediction of Therapeutic Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization Based on Pretherapeutic Dynamic CT and Textural Findings.
Park HJ; Kim JH; Choi SY; Lee ES; Park SJ; Byun JY; Choi BI
AJR Am J Roentgenol; 2017 Oct; 209(4):W211-W220. PubMed ID: 28813195
[TBL] [Abstract][Full Text] [Related]
38. Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics.
Kim J; Choi SJ; Lee SH; Lee HY; Park H
AJR Am J Roentgenol; 2018 Nov; 211(5):1026-1034. PubMed ID: 30240304
[TBL] [Abstract][Full Text] [Related]
39. Optimized Performance of FlightPlan during Chemoembolization for Hepatocellular Carcinoma: Importance of the Proportion of Segmented Tumor Area.
Joo SM; Kim YP; Yum TJ; Eun NL; Lee D; Lee KH
Korean J Radiol; 2016; 17(5):771-8. PubMed ID: 27587967
[TBL] [Abstract][Full Text] [Related]
40. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates.
Takayasu K; Muramatsu Y; Maeda T; Iwata R; Furukawa H; Muramatsu Y; Moriyama N; Okusaka T; Okada S; Ueno H
AJR Am J Roentgenol; 2001 Mar; 176(3):681-8. PubMed ID: 11222205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
